9-131072668-G-C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_006059.4(LAMC3):​c.3250G>C​(p.Glu1084Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00508 in 1,611,370 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1084K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0035 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0053 ( 35 hom. )

Consequence

LAMC3
NM_006059.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:12

Conservation

PhyloP100: 1.49

Publications

6 publications found
Variant links:
Genes affected
LAMC3 (HGNC:6494): (laminin subunit gamma 3) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 3. The gamma 3 chain is most similar to the gamma 1 chain, and contains all the 6 domains expected of the gamma chain. It is a component of laminin 12. The gamma 3 chain is broadly expressed in skin, heart, lung, and the reproductive tracts. In skin, it is seen within the basement membrane of the dermal-epidermal junction at points of nerve penetration. Gamma 3 is also a prominent element of the apical surface of ciliated epithelial cells of lung, oviduct, epididymis, ductus deferens, and seminiferous tubules. The distribution of gamma 3-containing laminins along ciliated epithelial surfaces suggests that the apical laminins are important in the morphogenesis and structural stability of the ciliated processes of these cells. [provided by RefSeq, Aug 2011]
LAMC3 Gene-Disease associations (from GenCC):
  • occipital pachygyria and polymicrogyria
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, Illumina
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005625963).
BP6
Variant 9-131072668-G-C is Benign according to our data. Variant chr9-131072668-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 194958.
BS2
High Homozygotes in GnomAdExome4 at 35 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006059.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMC3
NM_006059.4
MANE Select
c.3250G>Cp.Glu1084Gln
missense
Exon 19 of 28NP_006050.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMC3
ENST00000361069.9
TSL:2 MANE Select
c.3250G>Cp.Glu1084Gln
missense
Exon 19 of 28ENSP00000354360.4

Frequencies

GnomAD3 genomes
AF:
0.00348
AC:
529
AN:
152120
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00111
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00380
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00663
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00544
Gnomad OTH
AF:
0.00622
GnomAD2 exomes
AF:
0.00341
AC:
843
AN:
247176
AF XY:
0.00364
show subpopulations
Gnomad AFR exome
AF:
0.000693
Gnomad AMR exome
AF:
0.00233
Gnomad ASJ exome
AF:
0.00422
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000802
Gnomad NFE exome
AF:
0.00470
Gnomad OTH exome
AF:
0.00349
GnomAD4 exome
AF:
0.00525
AC:
7663
AN:
1459132
Hom.:
35
Cov.:
36
AF XY:
0.00537
AC XY:
3896
AN XY:
725758
show subpopulations
African (AFR)
AF:
0.000718
AC:
24
AN:
33420
American (AMR)
AF:
0.00220
AC:
98
AN:
44642
Ashkenazi Jewish (ASJ)
AF:
0.00341
AC:
89
AN:
26080
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.00530
AC:
455
AN:
85914
European-Finnish (FIN)
AF:
0.000829
AC:
44
AN:
53048
Middle Eastern (MID)
AF:
0.00601
AC:
26
AN:
4326
European-Non Finnish (NFE)
AF:
0.00592
AC:
6585
AN:
1111808
Other (OTH)
AF:
0.00568
AC:
342
AN:
60204
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
434
868
1301
1735
2169
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
262
524
786
1048
1310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00347
AC:
529
AN:
152238
Hom.:
0
Cov.:
32
AF XY:
0.00341
AC XY:
254
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.00111
AC:
46
AN:
41552
American (AMR)
AF:
0.00379
AC:
58
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00684
AC:
33
AN:
4826
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10608
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00543
AC:
369
AN:
67992
Other (OTH)
AF:
0.00616
AC:
13
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
26
52
77
103
129
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00439
Hom.:
0
Bravo
AF:
0.00317
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00597
AC:
23
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00465
AC:
40
ExAC
AF:
0.00329
AC:
399
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.00616
EpiControl
AF:
0.00600

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:12
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:6
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Dec 05, 2014
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 11, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LAMC3: BP4, BS2

Jun 06, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:2
May 15, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 06, 2020
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Nov 05, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Occipital pachygyria and polymicrogyria Benign:1
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

LAMC3-related disorder Benign:1
Jan 27, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Left ventricular noncompaction Benign:1
Feb 11, 2020
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
4.2
DANN
Benign
0.92
DEOGEN2
Benign
0.020
T
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.77
FATHMM_MKL
Benign
0.42
N
LIST_S2
Benign
0.64
T
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.0056
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L
PhyloP100
1.5
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.63
N
REVEL
Benign
0.050
Sift
Benign
0.31
T
Sift4G
Benign
0.45
T
Polyphen
0.41
B
Vest4
0.30
MVP
0.42
MPC
0.48
ClinPred
0.0053
T
GERP RS
1.1
Varity_R
0.043
gMVP
0.39
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146221263; hg19: chr9-133948055; API